A meta-analysis conducted by Pezzini et al. identified a significant association between the prothrombin G20210A mutation and PFO-related cerebral ischemia, with an odds ratio of 3.85 compared to healthy controls and 2.31 relative to stroke patients without a PFO. The gene discussed is F2; the disease is Patent foramen ovale.